Evidence map›Paper›PMID 41654847›Full record

ArticleJournal of translational medicine2026

Spatial resolution of the metastatic osteosarcoma tumor microenvironment using immunolabeling across murine, canine and human lung.

Jessica A Beck, Janice S Pereira, Kate I Silver, Lauren E McGee, Natalia von Muhlinen, Daniel R Rissi, Donna O Butcher, Elijah F Edmondson, Christina Mazcko, Amy K LeBlanc

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Jessica A BeckComparative Oncology Program, National Cancer Institute, National Institutes of Health, Building 10, Room 1B53, Bethesda, MD, USA. beck.1035@osu.edu.ORCID http://orcid.org/0000-0002-0145-7606
Janice S PereiraComparative Oncology Program, National Cancer Institute, National Institutes of Health, Building 10, Room 1B53, Bethesda, MD, USA.
Kate I SilverComparative Oncology Program, National Cancer Institute, National Institutes of Health, Building 10, Room 1B53, Bethesda, MD, USA.
Lauren E McGeeComparative Oncology Program, National Cancer Institute, National Institutes of Health, Building 10, Room 1B53, Bethesda, MD, USA.
Natalia von MuhlinenLaboratory of Human Carcinogenesis, National Cancer Institute, NIH, Bethesda, MD, USA.
Daniel R RissiAthens Veterinary Diagnostic Laboratory, Department of Pathology, College of Veterinary Medicine, University of Georgia, Athens, GA, USA.
Donna O ButcherMolecular Histopathology Laboratory, Laboratory Animal Science Program, Frederick National Lab for Cancer Research, Frederick, MD, USA.
Elijah F EdmondsonMolecular Histopathology Laboratory, Laboratory Animal Science Program, Frederick National Lab for Cancer Research, Frederick, MD, USA.
Christina MazckoComparative Oncology Program, National Cancer Institute, National Institutes of Health, Building 10, Room 1B53, Bethesda, MD, USA.
Amy K LeBlancComparative Oncology Program, National Cancer Institute, National Institutes of Health, Building 10, Room 1B53, Bethesda, MD, USA.

Funding

DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGSZ01BC006161 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI POMMIER, YVES · 1996 to 2008
$1.5M
Intramural NIH HHS Z01 BC006161NCI NIH HHS Z01-BC006161NIH Director's Challenge Award Program NIH Director's Challenge Award Program
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Animal disease modelsImmunohistochemistryLungMetastasisOsteosarcoma

Identifiers

PMID41654847
PMCPMC12973681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.